Local12—Machine perfusion leading to more organ viability for liver transplants

LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States.

Organ Recovery Systems (ORS) is honored to announce that UC Health, a Continued Access site in the PILOT clinical trial has set a record in 2023 for most transplants in the US! We are thankful for our ongoing collaboration with UC Health and their success using LifePort Liver Transporter.

“The last two years, we had the highest transplant rate in the United States,” said Dr. Shah. “Our median waiting time for a liver right now is 15 days. Nationally, it’s close to a year.”

This would not have been possible without the generosity of donor heroes and their families; thank you for giving the ultimate gift of a second chance at life.

View the full article here: local12.com/health/health-updates/machine-perfusion-organ-viability

Tagged In:

HMP, Liver

The Latest

Check out the most recent posts

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...

Kelley, Clinical and Technical Advisor

Kelley, Clinical and Technical Advisor

Before I joined Organ Recovery Systems last September as a Clinical and Technical Advisor, I was a Surgical Recovery Specialist in kidney and research organs at LifeSource, which is where I met ORS team members. The more I talked to them, the more I realized my...